The Ets transcription factors of the PEA3 group ± E1AF/PEA3, ETV1/ER81 and ERM ± are almost identical in the ETS DNA-binding and the transcriptional acidic domains. To accelerate our understanding of the molecular basis of putative diseases linked to ETV1 such as Ewing's sarcoma we characterized the human ETV1 and the mouse ER81 genes. We showed that these genes are both encoded by 13 exons in more than 90 kbp genomic DNA, and that the classical acceptor and donor splicing sites are present in each junction except for the 5' donor site of intron 9 where GT is replaced by TT. The genomic organization of the ETS and acidic domains in the human ETV1 and mouse ER81 (localized to chromosome 12) genes is similar to that observed in human ERM and human E1AF/PEA3 genes. Moreover, as in human ERM and human E1AF/ PEA3 genes, a ®rst untranslated exon is upstream from the ®rst methionine, and the mouse ER81 gene transcription is regulated by a 1.8 kbp of genomic DNA upstream from this exon. In human, the alternative splicing of the ETV1 gene leads to the presence (ETV1a) or the absence (ETV1b) of exon 5 encoding the Cterminal part of the transcriptional acidic domain, but without aecting the alpha helix previously described as crucial for transactivation. We demonstrated here that the truncated isoform (human ETV1b) and the fulllength isoform (human ETV1a) bind similarly speci®c DNA Ets binding sites. Moreover, they both activate transcription similarly through the PKA-transduction pathway, so suggesting that this alternative splicing is not crucial for the function of this protein as a transcription factor. The comparison of human ETV1a and human ETV1b expression in the same tissues, such as the adrenal gland or the bladder, showed no clear-cut dierences. Altogether, these data open a new avenue of investigation leading to a better understanding of the functional role of this transcription factor.
Introduction
The ets genes encode a family of eukaryotic transcription factors that includes more than 30 members from sponges to humans (for a review, see Sharrocks et al., 1997) . They have been involved both in tumorigenesis and in a number of developmental processes. Some of these genes become oncogenic by retroviral insertional mutagenesis (Moreau-Gachelin et al., 1988; Ben David et al., 1991) or by chromosomal translocations in myeloid leukemia (Shimizu et al., 1993; Golub et al., 1994 ) and Ewing's sarcomas (Delattre et al., 1992; Zucman et al., 1993) . For example, ETV1 was mapped at position 7p22 and submitted to a 7,22 translocation in a human Ewing's sarcoma (Jeon et al., 1995) .
The signature of the Ets family is the ETS domain (Karim et al., 1990 ) a domain of 85 amino acids, which binds to sites containing a central 5'-GGAA/T-3' motif. The structural motif of this domain has been determined, so permitting its classi®cation to the winged helix ± turn ± helix superfamily of DNA-binding domains (for review, see Sharrocks et al., 1997) . ETS domain transcription factors can be sub-classi®ed primarily because of the high amino acid conservation in their ETS domains and, in addition, in the conservation of other domains generally characterized as transactivating. This is the case for the PEA3 group, which is currently made up of three members, PEA3/ E1AF (Xin et al., 1992; Higashino et al., 1993 , Friedman et al., 1994 , ER81/ETV1 (Brown et al., 1992; Jeon et al., 1995; MonteÂ et al., 1995) and ERM (MonteÂ et al., 1994; Nakae et al., 1995; ChotteauLelieÁ vre et al., 1997) , which are more than 95% identical in the ETS domain and more than 85% in the 32 residue acidic domain (for review, see . This latter domain is responsible for the transcriptional activation of these factors via a 20 residue stretch predicted to form an alpha helix (Laget et al., 1996; Janknecht, 1996; Janknecht et al., 1996; Defossez et al., 1997) . In human, an alternative splicing of ETV1 leads to the presence (ETV1a) or the absence (ETV1b, previously named human ER81) of an exonic region encoding part of the acidic domain, but not aecting the alpha helix (Jeon et al., 1995; MonteÂ et al., 1995) .
The members of the PEA3 group are activated through both the Ras-dependent and other kinase pathways, a function which emphasizes their involvement in several oncogenic mechanisms (Janknecht, 1996; Janknecht et al., 1996) . Although the target genes of these transcription factors are multiple, their most frequently studied role concerns their involvement in the metastatic process. In fact, it has been shown that PEA3 group members are over expressed in metastatic human breast cancer cells and mouse mammary tumors (Trimble et al., 1993) , a feature which suggests a function of these transcription factors in mammary oncogenesis. Moreover, when human PEA3 is ectopically overexpressed in the nonmetastatic MCF-7 breast cancer cell line, the cells become metastatic in nude mice by activating the transcription of the matrix metalloprotease collagenase IV (Kaya et al., 1996) . In fact, the promoters of several matrix metalloproteases (Higashino et al., 1995) or adhesion molecules such as ICAM-1 are regulated by the PEA3 group members.
To accelerate our understanding of the molecular basis of putative diseases linked to ETV1 such as Ewing's sarcoma, we present here a detailed characterization of the human ETV1 and mouse ER81 genes, with speci®c reference to its exon ± intron structure and the sequence of the 5'-and 3'-untranslated regions. The mouse ER81 gene is compared to its human counterpart. Moreover, the functional role of the alternative splicing observed in the transcriptional domain of human ETV1 is depicted.
Results

Determination of human ETV1 genomic structure
Two human genomic l DNA fragments (a (16 kbp) and g (13 kbp)) and two human P1 DNA fragments b (80 kbp) and d (70 kbp)) were characterized ( Figure  2a ) through screening. The fragments were partially sequenced ( Figure 1 ) by means of primers derived from the two cDNA sequences (Jeon et al., 1995; MonteÂ et al., 1995) . Comparison with the cDNA con®rmed the sequence and showed that the human ETV1 gene contains 13 exons (GeneBank accession numbers: AF109620-AF109632). The largest exon is the last and contains the end of the ETS domain, the carboxyterminal domain and at least part of the 3'-untranslated region of ETV1. The 12 remaining exons varied from 48 bp (exon 4) to 248 bp (exon 8) ( Figure  1 ). As illustrated in Figure 2c , both the acidic and the ETS domains are included in three exons, but none of them starts or ends at a splicing site. The genomic organization of the ETS and acidic domains in the human ETV1 gene is similar to that observed in the human ERM (Monte et al., 1996) and human E1AF genes (MonteÂ et al., submitted) (Figure 2c,f) . The breakpoint for translocation observed in Ewing's sarcoma involving part of the ETV1 gene is situated between the exons 10 and 11 (Jeon et al., 1995 and for review, see de Launoit et al., 1997) . This site is roughly conserved in the other gene of the PEA3 group member involved in EWS translocation in Ewing's sarcoma, i.e. E1AF (Kaneko et al., 1996) . As depicted in Figure 1 , the consensus 3'-splice acceptor AG site is present in each intron characterized. The consensus 5'-splice donor site GT is present in each junction except for intron 9, where GT is replaced by TT. The length of the introns was characterized by PCR on genomic DNA with primers on the intron-exon junctions ( Figure 2a) . The smallest intron of 0.9 kbp was found between exons 2 and 3, and the largest that we were able to amplify was found between exons 4 and 5 with a size of 10.5 kbp (Figure 2a,d ). We were not able to amplify the introns between exons 5 and 6 or between exons 8 and 9, and this implies that these introns should be, either larger than 20 kbp, or dicult to amplify by the dierent PCR approaches used here. These experiments suggest that the human ETV1 gene is included in a locus larger than 100 kbp. Concerning the 5'-untranslated region, we have identi®ed the methionine common to all three PEA3 group members in the second exon. A ®rst untranslated exon is thus upstream from this methionine. We thus performed a primer extension assay in order to locate the 5'-end of the human ETV1 mRNA precisely. For this purpose we used a primer complementary to the two published cDNA at position +29 bp downstream from the ATG Figure 1 Partial genomic DNA sequence of the human ETV1 gene. The exons are numbered to the right, and the exon sequence is indicated by capital letters. The codons corresponding to the predicted protein-coding region are above their respective amino acids. The lengths of the introns are indicated between the 5'-and the 3'-¯anking nucleotides of each intron. The introns are shown by lower-case letters. The regions corresponding to the acidic and ETS domains are boxed. The vertical arrows numbered 1 and 2 correspond; for arrow number 1, to the 5'-ends of the ETV1b cDNA (MonteÂ et al., 1995) and for arrow number 2, to the 5'-end of the ETV1a cDNA (Jeon et al., 1995) . The vertical arrow numbered 3 corresponds to the 3'-end of the ETV1b cDNA and the arrow numbered 4 corresponds to the 3'-end of the ETV1a cDNA. The arrow numbered 5 corresponds to the 5'-end obtained after Primer Extension analysis (MonteÂ et al., 1995) . As indicated (arrow 5 in Figure  1) , the initiation start site should be 188 bp upstream from the translation initiation codon. The 3'-untranslated region is incomplete since Northern blot analyses revealed the presence of a major 4.6 ± 4.7 kb transcript and a minor 7.2 ± 7.5 kb transcript (Jeon et al., 1995; MonteÂ et al., 1995) . We can easily envisage a long 3'-untranslated region downstream from the stop codon.
Determination of mouse ER81 genomic structure
Three mouse genomic l DNA fragments (e (16 kbp), f (14 kbp) and Z (17 kbp)) were characterized through screening ( Figure 2b ). The genomic fragments were partially sequenced (Table 1) by means of primers derived from the cDNA sequence (Brown et al., 1992) . Comparison with this cDNA con®rmed the sequence and showed that the mouse ER81 gene contains 13 exons, as is the case for the human ETV1 gene (Table 1 and see GeneBank accession numbers AF109633-AF109642). We were not able to pick up a genomic l phage including exon 5, which contains the last nucleotides of the acidic domain. The genomic organization of the ETS and the acidic domains within the mouse ER81 gene (Table 1) is similar to that observed in the human ETV1 gene (Figure 1 ). The smallest intron of 427 bp was found between exons 1 and 2, and the largest that we were able to amplify was found between exons 12 and 13 with a size of 4.5 kbp (Table 1 and Figure 2e ). Using long range PCR experiments, we were not able to amplify the introns between exons 4 and 5, 5 and 6, or 8 and 9, a factor that indicates that these introns should be probably larger than 20 kbp. These experiments demonstrate that the mouse ER81 gene is included in a locus larger than 90 kbp. The genomic DNA of the e phage was subcloned in order to place the putative promoter region of the mouse ER81 gene upstream from the reporter luciferase gene in the pGL3 vector. The transfection of this reporter plasmid in human kidney carcinoma HEK-293 cells revealed a strong promoter activity of the vector containing the sense promoter region when compared to the pGL3 vector alone, since the luciferase activity was stimulated by sevenfold. This indicates that the region driving the mouse ER81 transcription is included in this 1.8 kbp region and now requires further detailed study.
Mapping of mouse ER81 (Etsrp81) in the vicinity of Meox2 on mouse chromosome 12
We determined the chromosomal localization of ER81 in mouse by radiation hybridization (RH) mapping as described in Material and methods. RH typing data of ER81 on the T31 RH panel were analysed together with those of STS markers available from the T31 RH database (http://www.jax.org/resources/documents/ cmdata/rhmap/rh.html). Two-point analysis indicated the location of ER81 on chromosome 12 in the vicinity of D12Mit59 with a LOD score of 6.6 (Figure 3 ). The human ortholog of mouse ER81, the ETV1 gene, has been localized to chromosome 7p22 by FISH (Jeon et al., 1995; Jeon and Shapiro, 1998) . ETV1 (D7S2837) has also been assigned by RH mapping to the interval between STS markers D7S664 and D7S2557 (Dib et al., 1996) . This region contains MOX2, of which the mouse ortholog, Meox2, was mapped to chromosome 12 by backcross study (Candia et al., 1992; Gorski et al., 1993) . Therefore, we included Meox2 in our RH mapping experiments. Two-point analysis indicated a strong linkage of Meox2 to ER81, and multi-point analysis established the following order (LOD 4.20): centromere, D12Mit59 (25.2 cR), Meox2 (31.9 cR), ER81 (Etsrp81), telomere (Figure 3) .
Comparison of the binding and transcriptional capacities of human ETV1a and ETV1b isoforms
As has previously been shown, the human ETV1b (previously called human ER81) transcript (MonteÂ et al., 1995) encodes a protein which lacks both the last 13 residues of the acidic domain and the ®ve residues contiguous to the carboxy-terminal part of the acidic domain of human full-length ETV1 (ETV1a) (Jeon et al., 1995) . In the present study we demonstrate unambiguously that the missing residues are encoded by a single exon. This exon corresponds to exon 5, which is localized between two large introns ( Figure  2a) . In order to examine the DNA-binding capacity of the two proteins we ®rst generated the full-length human ETV1a protein and its alternatively spliced form ETV1b by means of in vitro transcriptiontranslation, and then tested them for an interaction with the speci®c Ets-binding probe E74 (Janknecht, 1996) . As shown in Figure 4a , while proteins of the reticulocyte extracts from the empty pSV vector did not bind the probe (lane 1), both forms of in vitro translated ETV1 were able to interact with the E74 probe (lanes 2 and 3). However, both proteins showed similar DNA-binding capacities. To compare the two isoforms further we also performed co-transfection experiments in rabbit kidney RK13 cells in the presence of a luciferase reporter gene driven by the three times E74 Ets motifs. Taking into account the fact that transcriptional activation by PEA3 group members is enhanced by the PKA signaling pathway Brown et al., 1998) , the involvement of this pathway in regulating transcripis represented by the large box, which contains the acidic (hatched box) and the ETS (black box) domains; the¯anking 5'-and 3'-untranslated regions are shown as small boxes. The acidic and the ETS domains are each composed of three dierent exons. (d) Sizes of the larger human ETV1 introns using PCR on genomic DNA from human blood leukocytes. The positions of the speci®c primers are shown in (a) and listed under Material and methods. After an initial hot start, PCR was performed in two stages, ®rstly for 16 cycles: 938C for 1 min and 688C for 10 min, and secondly for 20 cycles: 938C for 1 min and 688C for 10 min with an increment of 15 s per cycle. The fragments resulting from ampli®cation with the indicated couples of primers were analysed on a 0.7% agarose gel. The sizes of the DNA fragments were obtained by the 1 kb ladder (Gibco BRL) and are positioned on the left. tion activation was used to compare the transactivation potency of human ETV1a and ETV1b isoforms. The expression of both ETV1a and ETV1b caused little inhibition to transcription under the basal levels when compared to cells transfected with the pSV vector (Figure 4b ). When the PKA was expressed, the luciferase transcription level within the basal condition was similar to that in the absence of the kinase. However, the co-expression of either human ETV1a or human ETV1b increased reporter activation approximately threefold in each case when compared to the luciferase activity obtained in cells transfected with the PKA and the pSV vectors. Altogether, these data suggest that the two isoforms of the human ETV1 proteins display similar properties as transcription factor.
Comparison of ETV1a and ETV1b expression in human tissues
We performed semi-quantitative RT ± PCR experiments in order to illustrate the dierential expression of the two alternatively spliced isoforms of the human ETV1 gene. In fact, it is not possible to use Northern blot experiments to detect two mRNA isoforms, which are 54 nucleotides dierent. For this purpose we used speci®c primers for each of the isoforms and performed RT ± PCR on RNA arising from human tumoral tissues (one sample per organ) and their corresponding normal tissues. In all the normal tissues tested, both isoforms were detected and as illustrated in Figure 5 for the bladder (Figure 5a ), the kidney (Figure 5b ) and the adrenal gland (Figure 5c ), each isoform present in a normal tissue was expressed to a greater extent than the corresponding isoform in the tumoral tissue. These data have also been observed in other tissues such as the placenta, the uterus and the spleen (data not shown).
Discussion
In this report, we characterized the genomic organization of the human ETV1 gene. This gene is composed of 13 exons and covers a genomic DNA region larger than 90 kbp. These data are in good agreement with The introns and exons are similarly numbered as in Figure 1 , and are shown by lower-and upper-case letters respectively. The lengths of the introns and the exons are indicated including the numbers of nucleotides presented at the boundaries. x corresponds to the intron sequence we were not able to obtain Figure 3 Chromosomal localization of the mouse ER81 gene. Localization was determined by radiation hybridization mapping using the T31 mouse radiation hybrid panel. Ampli®cation of ER81 (Etsrp81) gene speci®c sequence was performed with primers derived from untranslated regions of the last exons of ER81 and Meox2. The resulting data were analysed with the RHMAP 3.0 software package (Lunetta et al., 1996) those obtained on the genomic organization of ERM (Monte et al., 1996) and E1AF (MonteÂ et al., submitted) (Figure 2f ). In fact, although the three cDNAs and proteins of the PEA3 group contain a high level of sequence identity, nothing has been currently established on the conservation of the genomic organization. As in the case of other Ets family members such as tel (Baens et al., 1996) , the ETS domain of the three PEA3 group members is encoded by three exons with the same splicing sites. In contrast, the ETS domain of other members of this family is encoded by one exon like in fev (Peter et al., 1997) , or by two exons like in erf (Liu et al., 1997) . This suggests that the genomic organization of this domain is not conserved throughout the whole family, but is very similar in each group. In parallel, we also show that the transcriptional acidic domain is also encoded by three conserved exons. One of the slight dierences observed in the genomic organization of these three genes is the presence of introns larger than 20 kbp in ETV1 and ERM genes, whereas in E1AF, the largest one is about 9 kbp. It has been previously shown by both our group and others that the proteins encoded by these three genes are functionally very similar, particularly in their respective transcriptional capacities. For example, we have previously observed in mammalian cells, that human ERM, mouse PEA3 and human ETV1 proteins similarly transactivate either a reporter plasmid driven by three consensual Etsbinding sites or a reporter plasmid In vitro-translated proteins were used in gel retardation assays with 32 P-labeled E74 oligonucleotide. The empty expression vector pSV (7) was used for in vitro transcription translation instead of pSV-hETV1a (ETV1a) or pSV-hETV1b (ETV1b). (b) Transcriptional capacity of human ETV1a and human ETV1b. RK13 cells were transfected with 50 ng of the expression vectors pSV (control), pSV-hETV1a (ETV1a) or pSV-hETV1b (ETV1b), 50 ng RSV-bGal and 50 ng of the E74 3 -tk80-Luc reporter plasmid. The absence (pale gray) or presence (dark gray) of transfected PKA (150 ng) expression plasmid is indicated. Data are presented as fold activation with respect to the pSV control plasmid alone in the absence of exogenous PKA. Data represent the averages of three independent experiments carried out on duplicate samples Figure 5 Dierential expression of human ETV1a and ETV1b mRNAs in normal and neoplatic human tissues: (a) bladder (b) kidney (c) adrenal gland. cDNAs were submitted to PCR with speci®c primers of human ETV1a or ETV1b. A kinetic of 30, 35 and 40 PCR cycles was chosen. PCR products were separated on a 1% agarose gel. TBP control RT ± PCR was performed (see Material and methods) on the same RT ± PCR products showing the following ratios: bladder (tumor: 2.24, normal: 2.66), kidney (tumor: 5.14, normal: 4.54) and adrenal gland (tumor: 6.24, normal: 4.03) driven by part of the ICAM-1 promoter which contains an active Ets site . Altogether, these data suggest that the three PEA3 group members ± ERM, E1AF/PEA3 and ETV1/ ER81 ± are highly similar not only at protein level, but also at genomic organization and functional levels. At the present time, the signi®cant dierence observed between these three genes is their spatio-temporal expression patterns. In fact, when expressed in the mouse embryo, ER81 mRNA is present in the mesenchyme cells whereas ERM and PEA3 are rather expressed in the epithelial ones (Chotteau-LelieÁ vre et al., 1997). In adults, E1AF is only detected in the brain, the epididymis and the mammary gland, whereas ETV1 and ERM are expressed in a wider series of tissues (Xin et al., 1992 , Brown et al., 1992 MonteÂ et al., 1994 MonteÂ et al., , 1995 Chotteau-LelieÁ vre et al., 1997) .
Concerning the mouse ER81 genomic organization, we demonstrate here that the exon-intron junctions are the same as those observed in the human ETV1 gene. This is a very good argument in favor of the fact that mouse ER81 and human ETV1 genes are homologs. As has been shown for the human ETV1 gene, the mouse ER81 gene possesses consensus splice acceptor and donor sites at each junction except for the 5' donor site of intron 9 where GT is replaced by TT. We also showed that the mouse ER81 gene is localized to chromosome 12 in the vicinity of the Meox2 gene, which is the mouse ortholog of the MOX2; this latter being localized in the vicinity of ETV1, the human ortholog of the mouse ER81. In parallel, the genomic DNA upstream from the ®rst exon of the mouse ER81 gene was tested for its ability to activate transcription. Since this 1.8 kb of 5'-non-transcribed DNA has promoter activity in mouse (data not shown) and human cell lines, these data open a new avenue of study. In fact, the precise mapping of crucial transcription factor binding sites should be analysed on this promoter.
We recently characterized a human ETV1 transcript (ETV1b) which encodes a protein lacking the last 13 residues of the acidic domain and the ®ve residues contiguous to the carboxy-terminal part of the acidic domain of mouse ER81 (MonteÂ et al., 1995) . In parallel, full-length human ETV1 (ETV1a) was cloned (Jeon et al., 1995) . We thus showed that this domain is absent in human ETV1b following an alternative splicing within the same gene ETV1 (MonteÂ et al., 1995) . Here, we are interested in the functionality of this splicing since it is located in the transcriptional acidic domain (Janknecht, 1996 Laget et al., 1996) . For this purpose, we tested the respective DNA-binding activities and showed that, in gel analysis, they do bind the E74 sequence, an oligonucleotide speci®c of the Ets proteins. Clearly, no signi®cant dierence was observed. This was not surprising as long as the ETS domain was not aected by the alternative splice. In contrast, this splice aected the acidic domain. We have recently shown that part of this domain is structured in an alpha ± helix, which is crucial for transcriptional activation . In fact, when disrupted, this alpha ± helix did not confer any transcriptional activity. However, the alternative splice does not aect the residues contained in the alpha ± helix. Indeed, the last residues of the acidic domain are not predicted as being structured . In common with other Ets transcription factors (for review, see Sharrocks et al., 1997) and other PEA3 group members (for review, see , the data that we obtained here indicate that human ETV1a and human ETV1b proteins activate the transcription of a reporter gene driven by the E74 sequence in a similar manner. This suggests that the removal of the end of the conserved acidic domain is not crucial for the activation of the transcription. This has been con®rmed in other systems (data not shown) such as the activation of the ICAM-1 promoter in rabbit kidney cells and so indicates that they both act similarly as a transcription factor. As for the three PEA3 group members, which seem to act functionally in a similar manner but are dierentially expressed, the speci®city of the human ETV1a and human ETV1b proteins should be studied at expressional level. Thus RT ± PCR, with speci®c primers for each isoform of human ETV1, was used to distinguish their respective expression. We tested the expression of both isoforms on a series of human tumors and the corresponding normal tissues. We present here only three representative tissues. For the same tissue, semi-quantitative PCR indicates that the ETV1a/ETV1b ratio is near one in all the tissues tested; this suggests that these two isoforms are transcribed at the same level, probably by the same promoter. In contrast when, in almost all tissues tested, we compare the expression of one of the two isoforms in the normal tissue and in the corresponding tumoral tissue, each form was less expressed in the tumoral tissue. Although this is in good agreement with previous Northern data experiments showing that the human ETV1 gene is almost ubiquitously expressed in normal tissues and not or weakly expressed in human cancer cell lines (MonteÂ et al., 1995; Jeon et al., 1995) , this observation remains to be con®rmed on a wider series of tumors from the same origin.
In conclusion, although we have shown that both isoforms of human ETV1 are not functionally dierent, the characterization of human ETV1 and mouse ER81 genomic organization opens a new avenue of investigation to leading better understanding of the functional role of these transcription factors. The regulation of their transcription should be an interesting way of investigation.
Material and methods
Screening and characterization of genomic DNA clones
The screening was performed on approximately 10 6 recombinant phage plaques from a human genomic l dash II DNA library whose DNA was obtained from the NB4 lymphoblastic cell line after partial digestion with the restriction enzyme SauIIIA and from a mouse genomic l dash II DNA library whose DNA was obtained from male 129/Sv cells. The human ETV1a (Jeon et al., 1995) and the human ETV1b (MonteÂ et al., 1995) cDNAs as well as the mouse ER81 cDNA (Brown et al., 1992) were used as probes to screen the genomic libraries of the corresponding species. After hybridization, the ®lters were washed and autoradiographed for 12 h at 7808C, as described. After undergoing three puri®cation steps, the positive phages were isolated and the inserts were excised by dierent endonuclease digestions. The puri®ed genomic DNA inserts were subcloned into the polylinker of pBluescript SKII + (Stratagene, La Jolla, CA, USA) or PCRII (InVitrogen, San Diego, CA, USA The sizes of the introns were determined either by sequencing or by long range PCR using the AmpliTaq XL kit (Perkin-Elmer, Foster City, CA, USA). After an initial hot start, PCR was performed in two stages, ®rstly for 16 cycles: 938C for 1 min and 688C for 10 min, and secondly for 20 cycles: 938C for 1 min and 688C for 10 min with an increment of 15 s per cycle. The fragments resulting from ampli®cation with the couples of primers indicated were analysed on a 0.7% agarose gel. These primers are available under request by e-mail at the following address: delaunoi@infobiogen.fr.
Transactivation analyses
A genomic mouse DNA fragment of 1.8 kb containing the initiation codon and the 5' nontranscribed region of the mouse ER81 gene was puri®ed, subcloned into the polylinker of the pBluescript II SK + vector (Stratagene), and sequenced. This fragment was then subcloned into the polylinker of the pGL3 vector (Promega) in sense orientation (71748 to +98) upstream from the luciferase gene. The E74 3 -tk80-luc reporter plasmid and the over-expression vector for the protein kinase PKA were used as described . The full-length coding region of human ETV1 cDNA (ETV1a) (Jeon et al., 1995) and the cDNA lacking both the region encoding the last 13 residues of the acidic domain and the ®ve residues contiguous to the C-terminal part of this domain (ETV1b) (MonteÂ et al., 1995) were ampli®ed by PCR, digested and subcloned in EcoRI and BglII sites of the pSV vector (Laget et al., 1996; Defossez et al., 1997) in order to produce the pSV-hETV1a and the pSV-hETV1b, respectively. RK13 rabbit kidney carcinoma cells or HEK-293 human kidney carcinoma cells were maintained in Dulbecco medium containing 10% fetal calf serum (Gibco) and incubated at 378C in a water-saturated 5% CO 2 atmosphere. Transient transfection experiments were performed using the PEI Exgen 500 procedure (Euromedex, France) with a total of 300 ng DNA in 35 mm dishes. The assays were performed as described (Laget et al., 1996) ; the data presented are from three independent experiments using two dierent plasmid preparations.
Gel retardation assays
A 1 mg aliquot of the empty expression vector pSV, or the pSV-hETV1a and the pSV-hETV1b vectors was used for a combined in vitro transcription-translation reaction performed with the TNT coupled reticulocyte lysate system (Promega). Two ml of the reaction mix was then used for a gel retardation reaction with a 32 P-labeled oligonucleotide (MonteÂ et al., 1995; Janknecht, 1996; Janknecht et al., 1996) . The complexes were resolved on a 6% native acrylamide gel at 48C.
Radiation hybrid mapping
The T31 mouse radiation hybrid (RH) panel was purchased from Research Genetics (Huntsville, AL, USA), and DNA samples (25 ng) of the ®rst 94 RH lines were used in this mapping study. Following oligonucleotides were used for the ampli®cation of Etsrp81 gene speci®c sequences: 5'-GAGTAACCCGTCAAGACCGGC-3' and 5'-CTGAA-ATCAACTGTACCGTAGATCC-3' (389 bp product) and of Meox2 gene: 5'-CGTCACATCAACGAAGAGGACA-CAGTG-3' and 5'-CTGTAGGACTCCATTCCAAGCCTA-AGC-3' (421 bp product). Both primers were derived from untranslated regions of the last exons of Etsrp81 and Meox2. PCR was performed with 0.5 unit Taq polymerase (Gibco), 25 nM each dNTP, 10 mM Tris pH 9.0, 50 mM KCl, 1.5 mM MgCl 2 , and 200 nM from each primer in a total reaction volume of 25 ml. Samples were subjected to 35 ampli®cation cycles consisting of : 30 s at 948C, 30 s at 608C and 30 s at 728C (Gene Amp PCR System 9600, Perkin Elmer). PCR products were analysed by electrophoresis using a 2% agarose gel. The resulting data were analysed with the RHMAP 3.0 software package (Lunetta et al., 1996) .
RNA isolation and analysis of human tissues
In accordance with protocols approved previously by the human studies committee, tumoral and normal tissues were obtained from patients after surgery at the Institut Gustave Roussy (France). The tissues were immediately frozen in liquid nitrogen and stored at 7808C. RNA extraction was carried out by homogenizing the frozen tissues by means of RNazol (Cinna-Biotex) as described (MonteÂ et al., 1994) . The RT ± PCR method was used to quantify ETV1a ETV1b mRNAs. In order to take into account the extent of possible degradation of the RNA preparations, TBP transcripts were quanti®ed and used as control, as described (Lazar et al., 1995) . In a ®nal volume of 50 ml, the PCR protocol included 4 ml of the diluted RT (50 ng cDNA), 5 ml MgCl 2 15 mM, 2.5 ml dNTP 2 mM, 1.25 U DNA Taq polymerase with 10 pM of each couples of primers. PCR were processed through the number of cycles indicated, as described. PCR products were electrophoresed in a 1% agarose gel. The primers used for speci®cally amplifying human ETV1a and human ETV1b were as previously described (MonteÂ et al., 1995) . The TBP ratios were obtained by the quanti®cation of the internal TBP amount in relation to an external 12-bp longer arti®cially synthesized TBP product added to the PCR reaction, as described (Lazar et al., 1995) .
